11/08/2024
3:18 PM | CHYUNG YUNG H. (Reporting)
Keros Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
11/06/2024
3:22 PM | Keros Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/06/2024
7:02 AM | Keros Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/16/2024
7:01 AM | Keros Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/30/2024
7:00 AM | Keros Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/03/2024
7:01 AM | Keros Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/28/2024
7:01 AM | Keros Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
08/15/2024
4:06 PM | GORDON CARL L (Reporting)
Keros Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/15/2024
4:01 PM | Keros Therapeutics (Issuer)
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VII LLC (Reporting)
OrbiMed Genesis GP LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/13/2024
3:12 PM | Keros Therapeutics (Subject)
ORBIMED ADVISORS LLC (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/07/2024
3:02 PM | Keros Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/17/2024
4:15 PM | Keros Therapeutics (Filer)
| Form 424B5 | |
06/17/2024
4:17 PM | Keros Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/17/2024
5:07 AM | Keros Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/05/2024
3:10 PM | BIENAIME JEAN JACQUES (Reporting)
Keros Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
06/05/2024
3:11 PM | BIENAIME JEAN JACQUES (Reporting)
Keros Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
7:01 AM | Keros Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/03/2024
3:15 PM | Farzan Nima (Reporting)
Keros Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
3:15 PM | GORDON CARL L (Reporting)
Keros Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
3:15 PM | GRAY MARY ANN (Reporting)
Keros Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
3:15 PM | Keros Therapeutics (Issuer)
Knowles Julius (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
3:15 PM | Keros Therapeutics (Issuer)
Nussbaum Ran (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
3:15 PM | Kariv Tomer (Reporting)
Keros Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
3:15 PM | Keros Therapeutics (Issuer)
Seth Alpna (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
7:01 AM | Keros Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2024
7:01 AM | Keros Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2024
7:03 AM | Keros Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/03/2024
7:00 AM | Keros Therapeutics (Filer)
| Form S-3ASR | |
03/14/2024
7:01 AM | Keros Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/06/2024
7:01 AM | Keros Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/05/2024
7:01 AM | Keros Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/05/2024
7:02 AM | Keros Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/28/2024
3:02 PM | Keros Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/15/2024
7:37 PM | Cooper Simon Peter (Reporting)
Keros Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
7:38 PM | Keros Therapeutics (Issuer)
Rovaldi Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
7:40 PM | Keros Therapeutics (Issuer)
Regnante Keith (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
7:41 PM | Keros Therapeutics (Issuer)
Seehra Jasbir (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2024
5:38 PM | ALKEON CAPITAL MANAGEMENT LLC (Filed by)
Keros Therapeutics (Subject)
| Form SC 13G/A | |
02/09/2024
8:16 AM | FMR LLC (Filed by)
Keros Therapeutics (Subject)
| Form SC 13G/A | |
01/26/2024
4:26 PM | BlackRock Inc. (Filed by)
Keros Therapeutics (Subject)
| Form SC 13G/A | |
01/09/2024
7:01 AM | Keros Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
[625,000% Gain] – Are You Ready for the Next Altcoin Boom? (Ad) All of our key indicators are flashing the same signal: an altcoin season is fast approaching.
And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen. Register for the FREE Workshop Now & get $10 in Bitcoin |
01/08/2024
3:43 PM | Keros Therapeutics (Issuer)
Regnante Keith (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
3:02 PM | Keros Therapeutics (Filer)
| Form 424B5 | |
01/04/2024
3:04 PM | Keros Therapeutics (Subject)
Regnante Keith (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/04/2024
3:04 PM | Keros Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/03/2024
7:04 AM | Keros Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/13/2023
4:20 PM | Keros Therapeutics (Subject)
ORBIMED ADVISORS LLC (Filed by)
| Form SC 13D/A | |
12/11/2023
5:44 PM | Keros Therapeutics (Subject)
ORBIMED CAPITAL LLC (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/11/2023
5:02 AM | Keros Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Free KROS Stock Alerts